期刊文献+

晚期糖基化终产物受体异常表达对肿瘤发生和侵袭转移的影响 被引量:3

Role of abnormal expression of receptor for advanced glycosylation end products in carcinogenesis,tumor invasion,and metastasis
原文传递
导出
摘要 以往人们将晚期糖基化终产物受体(receptor for advanced glycosylation end products,RAGE)的研究重点放在糖尿病血管病变中。近年来的临床研究发现,RAGE在人肝癌、胃癌、胰腺癌和前列腺癌等多种肿瘤组织中均高表达,而在横纹肌肉瘤和肺癌组织中低表达。RAGE的异常表达与肿瘤的发生、血管生成和侵袭转移等恶性化程度密切相关。本文对不同肿瘤组织中RAGE的异常表达及其与肿瘤发生、发展的相关性进行简要综述。 Receptor for advanced glycosylation end products (RAGE) has long been a focus in studies of diabetic vascular diseases. Recently, clinical evidence has shown that the expression level of RAGE is high in liver, stomach, pancreas and prostate cancer tissues whereas the expression level of RAGE is lower in chondrosarcoma and lung cancer tissues. The abnormal expression of RAGE is closely associated with tumorgenesis, angiogenesis, tumor invasion and metastasis. This review summarizes the abnormal expression of RAGE in different tumors and its role in carcinogenesis and development of tumor.
出处 《肿瘤》 CAS CSCD 北大核心 2011年第10期957-960,共4页 Tumor
关键词 肿瘤 基因表达 肿瘤转移 晚期糖基化终产物受体 Neoplasms Gene expression Neoplasm metastasis Receptor for advanced glycosylation end products
  • 相关文献

参考文献39

  • 1HUDSO B I, CARTER A M, HARJA E, et al. Identification, classification, and expression of RAGE gene splice variants[J]. FASEBJ, 2008, 22(5): 1572-1580.
  • 2KOCH M, CHITAYAT S, DATTILO B M, et al. Structural basis for ligand recognition and activation of RAGE [J]. Structure, 201 O, 18(10): 1342-1352.
  • 3YAN S F, RAMASAMY R, SCHMIDT A M. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications[J]. Nat Clin Pract Endocrinol Metab, 2008.4(5): 285-293.
  • 4ALEXlOU P, CHATZOPOULOU M, PEGKLIDOU K, et al. RAGE: a multi-ligand receptor unveiling novel insights in health and disease [J]. Curt Med Chem, 2010, 17(21 ):2232-2252.
  • 5PIETKIEWlCZ J, SEWERYN E, BARTYS A, et al. Receptors for advanced glycation end products and their physiological and clinical significance [J]. Postepy Hig Med Dosw, 2008, 62:511-523.
  • 6MOSQUERA J A. Role of the receptor for advanced glycation end products (RAGE) in inflammation[J]. Invest Clin, 2010, 51(2): 257-268.
  • 7YAMAGISHI S, NAKAMURA K, MATSUI T, et al. Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication[J].CurrPharm Des, 2008, 14(5): 487-495.
  • 8REINIGER N, LAU K, McCALLA D, et al. Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function inthe diabetic OVE26 mouse[J]. Diabetes, 2010, 59(8): 2043-2054.
  • 9GEBHARDT C, RIEHL A, DURCHDEWALD M, et al. RAGE signaling sustains inflammation and promotes tumor development [J].J Exp Med, 2008, 205(2): 275-285.
  • 10TAGUCHI A, BLOOD D C, DEL TORO G, et al. Blockade of RAGE-amphoterin signaling suppresses tumour growth and metastases [J]. Nature, 2000, 405(6784): 354-360.

二级参考文献16

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2Thawley, S. E. ,W. R. Panje. Comprehensive management of head and neck tumors, 1987 ( 1 ) : 1911.
  • 3Yamagishi, S. , et al. Role of advanced glyeation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy. Int J Clin Pharmacol Res, 2003,23 (4): 129-34.
  • 4Taguchi, A. , et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature, 2000,405 (6784) : 354 -360.
  • 5Hiwatashi, K. , et al. A novel function of the receptor for advanced glycation end-products ( RAGE ) in association with tumorigenesis and tumor differentiation of HCC. Ann Surg Oneol, 2008,15 (3) : 923-933.
  • 6Tsuji, A, et al. Induction of receptor for advanced glycation end products by EBV latent membrane protein 1 and its correlation with angiogenesis and cervical lymph node metastasis in nasopharyngeal carcinoma. Clin Cancer Res, 2008,14(17) :5368-5375.
  • 7Weidner, N. , Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 1995,147(1) : 9-19.
  • 8Schmidt, A. M. , et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Bial Chem, 1992,267 (21) :4987-4997.
  • 9Hudson, B. I. , et aJ. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Racl and Cdc42. J Biol Chem, 2008,283 (49) :34457-34468.
  • 10Sparvero, L. J. , et al. RAGE ( Receptor for Advanced Glycation Endproducts ), RAGE ligands, and their role in cancer and inflammation. J Transl Med, 2009,7 : 17.

共引文献11

同被引文献19

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部